ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
Giulia Marvaso, Giulia Corrao, Mattia Zaffaroni, Maria Giulia Vincini, Chiara Lorubbio, Sara Gandini, Cristiana Fodor, Sofia Netti, Dario Zerini, Stefano Luzzago, Francesco Mistretta, Konstantinos Venetis, Giulia Cursano, Tiziana Burla, Ketti Mazzocco, Federica Cattani, Giuseppe Petralia, Nicola Fusco, Gabriella Pravettoni, Gennaro Musi, Ottavio De Cobelli, Chad Tang, Piet Ost, David A. Palma, Roberto Orecchia, Barbara Alicja Jereczek‐Fossa
Topics & Concepts
Prostate cancerOpen labelMedicineOncologyRandomized controlled trialInternal medicineClinical trialUrologyCancerProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and Applications